New York, July 31, 2014 -- The continued pressure on Medicare Advantage (MA) reimbursements to health insurers will impact health insurers although for most, the credit implications will be manageable and ratings are expected to be unaffected, says Moody's Investors Service in its latest report "Medicare Advantage Cuts: Prognosis Not Bad for Most Health Insurers."

Vollständigen Artikel bei Moodys lesen